l. Brunner, F.: A serological investigation of the Corylaceae. Master´s Thesis (Botany), Rutgers University, New Brunswick, N. J., USA, 1977 (in English).
2. Brunner, F.: Pharmakokinetik von 14C-Bencyclan und 14C-Tofizopam an Ratte und Mensch. Ph. D. Thesis (Pharmacology), University of Graz, Austria, 1979 (in German).
3. Brunner, F.: La liaison plasmatique d´un anti-inflammatoire non-stéroidique, le F 1594, chez l´homme. Mémoire Assistant Etranger (Foreign University Assistant´s Thesis), Université de Paris XII (Créteil), 1982 (in French).
4. Brunner, F., Fairbrothers, D. E.: Serological relationships within the Cornales. Serol. Museum Bull. 53, 2-5, 1978.
5. Brunner, F., Fairbrothers, D. E.: Serological investigation of the Corylaceae. Bull. Torr. Bot. Club 106, 97-103, 1979.
6. Vergin, H., Ferber, H., Brunner, F., Kukovetz, W. R.: Pharmakokinetik und Biotransformation von Oxametacin bei gesunden Probanden. Arzneim.-Forsch./Drug Res. 31(I), 513-518, 1981.
7. Kukovetz, W. R., Brunner, F., Beubler, E., Weyhenmeyer, R., Lohaus, R, Gross, M., Mayer, D.: Single dose pharmacokinetics of fendiline in humans. Eur. J. Drug Met. Pharmacokin. 7, 105-110, 1982.
8. Brunner, F., Zini, R., Tillement, J.-P.: Dependence of drug-protein binding parameters on human serum and albumin concentration. J. Pharm. Pharmacol. 35, 526-528, 1983.
9. Brunner, F., Zini, R., Tillement, J.-P.: Plasma protein binding of metbufen, a new non-steroid anti-inflammatory drug, in humans. Int. J. Clin. Pharmacol. Ther. Tox. 22, 134-139, 1984.
10. Barré, J., Houin, G., Brunner, F., Brée, F., Tillement, J.-P.: Disease-induced modifications of drug pharmacokinetics. Int. J. Clin. Pharm. Res. 3, 215-226, 1983.
11. Houin, G., Brunner, F., Nebout, Th., Cherfaoui, M., Lagrue, G., Tillement, J.-P.: The effects of chronic renal insufficiency on the pharmacokinetics of doxycycline in man. Br. J. Clin. Pharmacol. 16, 245-252, 1983.
12. Brunner, F., Pöch, G.: Assessment of adrenergic β-blockade in the anesthetized rat at different baseline values. Gen. Pharmacol. 15, 233-237, 1984.
13. Pöch, G., Brunner, F.: The underlying bases of pharmacological results in agreement or disagreement with the Law of Initial Value. Gen. Pharmacol. 15, 229-232, 1984.
14. Morin, D., Zini, R., Brunner, F., Sebille, B., Tillement, J.-P.: Thermodynamic study of iodocyanopindolol-β-adrenoceptor interactions with rat lung and cerebral cortex. J. Recep. Res. 3, 773-790, 1983-84.
15. Brunner, F., Müller, W. E.: Prazosin binding to human α1-acid glycoprotein (orosomucoid), human serum albumin, and human serum. Further characterization of the "basic drug binding site" of orosomucoid. J. Pharm. Pharmacol. 37, 305-309, 1984.
16. Brunner, F., Kukovetz, W. R.: Muscarinic receptors of the vascular bed: Radioligand binding studies on bovine splenic veins. J. Cardiovasc. Pharmacol. 8, 712-721, 1986.
17. Brunner, F., Waelbroeck, M., Christophe, J.: Secoverine is a non-selective muscarinic antagonist on rat heart and brain receptors. Eur. J. Pharmacol. 127, 17-25, 1986.
18. Müller, W. E., Rick, S., Brunner, F.: Drug binding to human α1-acid glycoprotein - Focus on a single binding site, in: Protein binding and drug transport, Tillement, J.-P., Lindenlaub, E. (Eds.), Symposia Medica Hoechst 20, 29-44, 1986.
19. Brunner, F., Müller, W. E.: The stereoselectivity of the "single drug binding site" of human α1-acid glycoprotein (orosomucoid). J. Pharm. Pharmacol. 39, 986-990, 1987.
20. Brunner, F., Kukovetz, W. R.: Muscarinic receptor binding of alinidine and AQ-A 39 in guinea-pig myocardium, in: International symposium on muscarinic cholinergic mechanisms, Cohen, S., Sokolovsky, M. (Eds.), Freund Publ. House, London, 70-75, 1987.
21. Brunner, F., Kukovetz, W. R.: Binding of two specific bradycardic agents, alinidine and AQ-A 39, to muscarinic receptors of guinea pig atria and ventricle. J. Cardiovasc. Pharmacol. 11, 222-229, 1988.
22. Brunner, F., Kukovetz, W. R.: Characterization of guinea-pig cardiac muscarinic receptors by radioligand dissociation kinetics. Eur. J. Pharmacol. 151, 249-257, 1988.
23. Schubert, T., Brunner, F., Müller, W. E.: The interaction of RS 86, a centrally acting m-cholinoceptor agonist with M1 and M2 receptors in rat brain and rat heart, respectively. Pharmacopsychiatry. 21, 321-323, 1988.
24. Groschner, K., Ulle, P., Brunner, F., Kukovetz, W. R.: Interaction of DPI 201-106 with cardiac muscarinic receptors. Eur. J. Pharmacol. 159, 125-132, 1989.
25. Brunner, F.: Subclassification of atrial and intestinal muscarinic receptors of the rat - Direct binding studies with agonists and antagonists. Br. J. Pharmacol. 97, 572-578, 1989.
26. Brunner, F., Kolmayr, U., Kukovetz, W. R.: Pharmacokinetics and metabolism of the antiarrhythmic agent [3H]-Diprafenone in the rat. Arzneim.-Forsch./Drug Res. 39, 1430-1435, 1989.
27. Gillard, M., Brunner, F., Waelbroeck, M., Svoboda, M., Christophe, J.: Bretylium tosylate binds selectively to muscarinic receptors labelled by (3H)-Oxotremorine-M (SH receptors) in rat heart and brain. Eur. J. Pharmacol. 160, 117 -124, 1989.
28. Brunner, F.: Muscarin-Rezeptor-Differenzierung. Österr. Apoth. Zeit. 43, 694-700, 1989.
29. Brunner, F., Kukovetz, W. R.: Pharmakokinetik und Metabolismus von 14C-3H-Diprafenon HCl an der Ratte, in: Neue Aspekte in der Therapie mit Antiarrhythmica, Bender, F., Gülker, H. (Eds.), Steinkopf Verlag Darmstadt, 69-78, 1990.
30. Kukovetz, W. R., Brunner, F.: Pharmakokinetische Studien am Tier, in: Toxikologische und klinisch-pharmakologische Prüfungen, Grosdanoff, P., Kraupp, O., Schulte-Hermann, R., Schütz, W. (Eds), Walter de Gruyter Berlin-New York, 445-456, 1990.
31. Brunner, F., Kühberger, E., Brockmeier, D., Kukovetz, W. R.: Evidence for muscarinic receptors in endothelial cells from combined functional and binding studies. Eur. J. Pharmacol. 187, 145-154, 1990.
32. Brunner, F., Kühberger, E., Schloos, J., Kukovetz, W. R.: Characterization of muscarinic receptors of bovine coronary artery by functional and radioligand binding studies. Eur. J. Pharmacol. 196, 247-255, 1991.
33. Brunner, F., Kühberger, E., Groschner, K., Pöch, G., Kukovetz, W. R.: Characterization of muscarinic receptors mediating endothelium-dependent relaxation of bovine coronary artery. Eur. J. Pharmacol. 200, 25-33, 1991.
34. Brunner, F., Kukovetz, W. R.: Radioligand binding to muscarinic receptors of bovine aortic endothelial cells. Br. J. Pharmacol. 102, 373-380, 1991.
35. Pöch, G., Brunner, F., Kühberger, E.: Construction of antagonist dose-response curves for estimation of pA2-values by Schild-plot analysis and detection of allosteric interactions. Br. J. Pharmacol. 106, 710-716, 1992.
36. Stoschitzky, K., Lindner, W., Egginger, G., Brunner, F., Obermayer-Pietsch, B.., Passath, A., Klein, W.: Racemic (R,S)-propranolol versus half-dosed optically pure (S)-propranolol in humans at steady state: Hemodynamic effects, plasma concentrations, and influence on thyroid hormone levels. Clin. Pharmacol. Ther. 51, 445-453, 1992.
37. Brunner, F., du Toit, E. F., Opie, L. H.: Endothelin release during ischaemia and reperfusion of isolated perfused rat hearts. Mol. Cell. Cardiol. 24, 1291-1305, 1992.
38. Mayer, B., Brunner, F., Schmidt, K.: Inhibition of nitric oxide synthesis by methylene blue. Biochem. Pharmacol. 45, 367-374, 1993 .
39. Mayer, B., Brunner, F., Schmidt, K.: Novel actions of methylene blue. Eur. Heart J. 14 (Suppl. I), 22-26, 1993.
40. Klatt, P., Schmidt, K., Brunner, F., Mayer, B.: Inhibitors of brain nitric oxide synthase. J. Biol. Chem. 269, 1674-1680, 1994.
41. Kühberger, E., Groschner, K., Kukovetz, W. R., Brunner, F.: The role of myoendothelial cell contact in non-nitric oxide-, non-prostanoid-mediated endothelium-dependent relaxation of porcine coronary artery. Br. J. Pharmacol. 113, 1289-1294, 1994.
42. Brunner, F., Stessel, H., Simecek, S., Graier, W., Kukovetz, W. R.: Effect of intracellular Ca2+ concentration on endothelin-1 secretion. FEBS Lett. 350, 33-36, 1994.
43. Brunner, F.: Regulation of basal endothelin-1 secretion: Role of Ca2+ and protein kinase C. Biochem. Pharmacol. 49, 1785-1791, 1995
44. Brunner, F.: Tissue endothelin-1 levels in perfused rat heart following stimulation with agonist and in ischaemia and reperfusion. J. Mol. Cell. Cardiol. 27, 1953-1963, 1995.
45. Brunner, F., Stessel, H., Graier, W. F.: The effects of intracellular Ca2+ concentration and hypoxia on basal endothelin-1 secretion by cultured porcine aortic endothelial cells, in: Mediators in the cardiovascular system: regional ischemia. Agen. Act. (Suppl.) 45, 269-273, 1995.
46. Brunner, F., Mouton, R., Lochner, A., Opie, L. H.: Implication of inositol-1,4,5-trisphosphate in stretch-induced ANP release in hypertensive and normotensive rats: possible role of the inositol phosphate pathway in the development of hypertension. J. Cardiovasc. Pharmacol. 25, 168-176, 1995.
47. Brunner, F., Stessel, H., Watzinger, N., Löffler, B.-M., Opie, L. H.: Binding of endothelin-1 to plasma proteins and tissue receptors: effects on endothelin determination, vasoactivity, and tissue kinetics. FEBS Lett. 373, 97-101, 1995.
48. Brunner, F.: Cardiac tissue endothelin-1 levels under basal, stimulated, and ischemic conditions. J. Cardiovasc. Pharmacol. 26 (Suppl. 3), S44-S46, 1995.
49. Brunner, F., Stessel, H., Kukovetz, W. R.: Novel guanylyl cyclase inhibitor, ODQ reveals role of nitric oxide, but not of cyclic GMP in endothelin-1 secretion. FEBS Lett. 376, 262-266. 1995.
50. Brunner, F., Schmidt, K., Nielsen, E. B., Mayer, B.: Effect of potent novel guanylyl cyclase inhibitor on cGMP levels in endothelial cells and on relaxation in bovine pulmonary artery. J. Pharmacol. Exp. Ther. 277, 48-53, 1996.
51. Brunner, F., Kukovetz, W.R.: Post-ischemic anti-arrhythmic effects of ACE inhibitors: role of suppression of endogenous endothelin secretion. Circulation 94, 1752-1761, 1996.
52. Pfeiffer, S., Leopold, E., Schmidt, K., Brunner, F., Mayer, B.: Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine. Br. J. Pharmacol. 118, 1433-1440, 1996.
53. Brunner, F., Doherty, A. M.: Role of ETB receptors in local clearance of endothelin-1 in rat heart: studies with the antagonists PD 155080 and BQ-788. FEBS Lett. 396. 238-242, 1996.
54. Brunner, F., Leonhard, B., Kukovetz, W. R., Mayer B.: Role of endothelin, nitric oxide and L-arginine release in ischaemia/reperfusion injury of rat heart. Cardiovasc. Res. 36, 60-66, 1997.
55. Brunner, F.: Interaction of nitric oxide and endothelin-1 in ischemia/reperfusion injury of rat heart. J. Mol. Cell. Cardiol. 29, 2363-2374.
56. Schuller-Petrovic, S., Siedler, S., Kern, T., Meinhart, J., Schmidt, K., Brunner, F.: Imbalance between the endothelial cell-derived contracting factors prostacyclin and angiotensin II and nitric oxide/cyclic GMP in human primary varicosis. Br. J. Pharmacol. 122, 772-778, 1997.
57. Brunner, F., Opie, L. H.: Role of endothelin-A receptors in ischemic contracture and reperfusion injury. Circulation 97, 391-398, 1998.
58. Mayer, B., Pfeiffer, S., Schrammel, A., Koesling, D., Schmidt, K., Brunner, F.: A new pathway of nitric oxide/cyclic GMP signalling involving S-nitrosoglutathione. J. Biol. Chem. 273, 3264-3270, 1998.
59. du Toit, E. F., Miyashiro, J., McCarthy, J., Opie, L.H., Brunner, F.: Effect of nitrovasodilators and inhibitors of nitric oxide synthase on ischaemic and reperfusion function of rat isolated hearts. Br. J. Pharmacol. 123, 1159-1167, 1998.
60. Brunner, F., Wascher, T. C.: Contribution of the endothelium to transcapillary insulin transport in isolated perfused hearts. Diabetes 47, 1127-1134, 1998.
61. Stangl, K., Dschietzig, T., Alexiou, K., Brunner F.: Antithrombin increases pulmonary endothelins: inhibition by heparin and Ca2+ channel antagonism. Eur. J. Pharmacol. 370, 57-61, 1999.
62. Brunner, F.: Coronary vascular and interstitial levels of endothelin and big endothelin in right-heart hypertrophy due to monocrotaline-induced pulmonary hypertension in rat. Cardiovasc. Res. 44, 197-206, 1999.
63. Dschietzig, T., Alexiou, K., Laule, M., Becker, R., Schrör, K., Baumann, G, Brunner, F., Stangl, K.: Stimulation of pulmonary big endothelin-1 and endothelin-1 by antithrombin III: A rationale for combined application of antithrombin III and endothelin antagonists in sepsis related acute respiratory distress syndrome? Crit. Care Med. 28, 2445-2449, 2000.
64. Brunner, F., Wölkart, G., Pfeiffer, S., Russell, J. C., Wascher, T. C.: Vascular dysfunction and myocardial contractility in the JCR:LA-corpulent rat. Cardiovasc. Res. 47, 150-158, 2000.
65. Wascher, T. C., Wölkart, G., Russell, J. C., Brunner, F.: Delayed insulin transport across endothelium in insulin resistant JCR:LA-cp rats. Diabetes 49, 803-809, 2000.
66. Wölkart, G., Strömer, H., Brunner, F.: Calcium handling and role of endothelin-1 in monocrotaline right ventricular hypertrophy of the rat. J. Mol. Cell. Cardiol. 32, 1995-2005, 2000.
67. Brunner, F., Wölkart, G.: Endothelial NO/cGMP system contributes to natriuretic peptide-mediated coronary and peripheral vasodilation. Microvasc. Res. 61, 102-110, 2001.
68.Brunner, F., Hofmann, C. Schuller-Petrovic, S.: Responsiveness of human varicose saphenous veins to vasoactive agents. Br. J. Clin. Pharmacol. 51, 219-224, 2001.
69. Brunner, F., Wölkart, G.: Relaxant effect of C-type natriuretic peptide involves endothelium and nitric oxide-cGMP system in rat coronary microvasculature. Cardiovasc. Res. 51, 577-584, 2001.
70. Brunner, F., Andrew, P., Wölkart, G., Zechner, R., Mayer, B.: Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Circulation 104, 3097-3102, 2001.
71. Brunner, F., Wölkart, G., Haleen, S.H.: Defective intracellular calcium handling in monocrotaline-induced right ventricular hypertrophy: protective effect of long-term endothelin-A receptor blockade with (2-benzo[1,3]dioxol-5-yl-3-benzyl-4-(4-methoxy-phenyl-)-4-oxobut-2-enoate sodium (PD 155080). J. Pharmacol. Exp. Ther. 300, 442-449, 2002.
72. Suessenbacher, A., Lass, A., Mayer, B., Brunner, F.: Antioxidative and myocardial protective effects of L-arginine in oxygen radical-induced injury of isolated perfused rat hearts. Naunyn-Schmiedeb. Arch. Pharmacol. 365. 269-276. 2002.
73. Lass, A., Suessenbacher, A., Wölkart, G., Mayer, B., Brunner F.: Functional and analytical evidence for scavenging of oxygen radicals by L-arginine. Mol. Pharmacol. 61, 1081-1088, 2002.
74. Schuller-Petrovic, S., Stessel, H., Brunner, F.: Ca2+ mobilization in saphenous vein smooth muscle cells derived from patients with primary varicosity. Eur. J. Clin. Invest. 32, 649-656, 2002.
75. Brunner, F., Andrew, P., Wölkart, G., Zechner, R., Mayer, B.: Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Cardiovasc. Res. 57, 55-62, 2003.
76. Nöhammer, C., Brunner, F., Wölkart, G., Staber, P.B., Steyrer, E., Gonzales, F.J., Zechner, R., Hoefler, G.: Myocardial dysfunction and male mortality in peroxisome proliferator-activated receptor alpha knockout mice overexpressing lipoprotein lipase in muscle. Lab. Invest. 83, 259-270, 2003.
77. Brunner, F., Wölkart, G.: Peroxynitrite-induced cardiac depression: role of myofilament desensitization and cGMP pathway. Cardiovasc. Res. 60, 355-364, 2003.
78. Stessel, H., Brunner, F.: Effect of endothelin antagonism on contractility, intracellular calcium regulation and calcium regulatory protein expression in right ventricular hypertrophy of the rat. Bas. Clin. Pharmacol. Toxicol. 94, 37-45, 2004.
79. Wölkart, G., Stessel, H., Brunner, F.: In vivo administration of D-arginine: effects on blood pressure and vascular function in angiotensin II-induced hypertensive rats. Atherosclerosis 176, 219-225, 2004.
80. Kollau, A., Hofer, A., Russwurm, M., Koesling, D., Keung, W.M., Schmidt, K., Brunner, F. Mayer, B.: Contribution of aldehyde dehydrogenase to mitochondrial bioactivation of nitro-glycerin: evidence for the activation of purified soluble guanylate cyclase through direct formation of nitric oxide. Biochem. J. 385, 769-777, 2005.
81. Toller, W., Wölkart, G., Stranz, C., Metzler, H., Brunner, F.: Contractile action of levosimendan and epinephrine during acidosis. Eur. J. Pharmacol. 507, 199-209, 2005.
82. Brunner, F., Brás-Silva, C., Cerdeira, A.S., Leite-Moreir, A.F.: Cariovascular endothelins: Essential regulators of cardiovascular homeostasis. Pharmacol. Ther. 111, 508-531, 2006.
83. Wölkart, G., Kaber, G., Kojda G., Brunner, F.: Role of endogenous hydrogen peroxide in cardiovascular ischaemia/reperfusion function: studies in mouse hearts with catalase-overespression in the vascular endothelium. Pharmacol. Res. 54,558-564, 2006.
84. Wölkart, G., Stessel, H., Saad Z., Kirchengast M., Brunner F.: Cardioprotective effects of atrasentan, an endothelin-A receptor antagonist, but not of nitric oxide in diabetic mice with myocyte-specific overexpression of entothelial nictric oxide synthase. Br.J. Pharmacol. 148, 671-681, 2006.
85. Pozo-Nacas, B., Stessel, H., Wölkart, G., Brunner, F.: Role of myocardial nitric oxide in diabetic ischemia-reperfusion dysfunction: Studies in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. J Pharmacol. Exp. Ther. 319,729-738, 2006.
86. du Toit, E.F., Gendade, S., Carlini, S., Moolman, J.A., Brunner, F., Lochner, A.: Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model. Eur. J. Pharmacol. 556, 115-120, 2007.
87. Hammoud, L., Xiang, F., Lu, X., Brunner, F., Leco, K., Feng, Q.: Endothelial nitric oxide synthase promotes neonatal cardiomyocyte proliferation by inhibiting tissue inhibitor of metalloproteinase- 3 expression. Cardiovasc. Res. 2007 (doi: 10.1016/j. cardiores. 2007.05.2006).
88. Wölkart, G., Pang, X., Stessel, H., Kirchengast, M., Brunner, F.: Chronic endothelin- A receptor antagnosm is as protective as angiotensin converting enzyme inhibition against cardiac dysfuntion in diabetic rats. Br. J. Pharmacol. 151, 1187-1197, 2007.
89. Schuller-Petrovic, S., Wölkart, G., Höfler, G., Neuhold, N., Freisinger, F., Brunner, F.: Tissue-toxic effects of phosphatidylcholine/deoxycholate after subcutaneous injeciont for fat dissolution in rats and a human volunteer, Der. Surg. 2007 (in press).